MPNST
Clinical trials for MPNST explained in plain language.
Never miss a new study
Get alerted when new MPNST trials appear
Sign up with your email to follow new studies for MPNST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat sarcomas: Triple-Drug attack enters testing
Disease control Not yet recruitingThis study is testing a new combination of three drugs (selumetinib, ZEN-3694, and durvalumab) for people with advanced sarcomas that have not responded to standard treatments. The first part of the trial will find safe doses, and the second part will focus on a specific, aggress…
Matched conditions: MPNST
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Cancer-Detecting pen tested in surgery
Diagnosis Not yet recruitingThis study is testing a handheld pen-like device that analyzes tissue during surgery. The goal is to see if it can quickly and accurately tell the difference between normal tissue, benign nerve tumors (neurofibromas), and a rare, aggressive cancer called MPNST. This could help su…
Matched conditions: MPNST
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC